Ambrx Biopharma, Inc. (AMAM)

NYSE: AMAM · IEX Real-Time Price · USD
3.85
-0.15 (-3.75%)
May 20, 2022 4:00 PM EDT - Market closed

Total Valuation

AMAM has a market cap or net worth of $148.57 million. The enterprise value is -$9.21 million.

Market Cap148.57M
Enterprise Value-9.21M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

AMAM has 38.59 million shares outstanding.

Shares Outstanding38.59M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)51.08%
Float14.91M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio19.93
PB Ratio0.78
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 7.19, with a Debt / Equity ratio of 0.07.

Current Ratio7.19
Quick Ratio7.00
Debt / Equity0.07
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -269.40%, which is considered low. The company has a ROIC of -2,080.00%.

Return on Equity (ROE)-269.40%
Return on Assets (ROA)-37.50%
Return on Capital (ROIC)-2,080.00%
Revenue Per Employee$92,037
Profits Per Employee-$840,481
Employee Count81
Asset Turnover0.04
Inventory Turnovern/a

Taxes

In the past 12 months, AMAM has paid $1,000 in taxes.

Income Tax1,000
Effective Tax Raten/a

Stock Price Statistics

Beta (1Y)n/a
Total Price Change-78.61%
50-Day Moving Average3.97
200-Day Moving Average6.37
Average Volume (30 Days)6,958

Short Selling Information

The latest short interest is 5,598, so 0.01% of the outstanding shares have been sold short.

Short Interest5,598
Short % of Shares Out0.01%
Short % of Float0.04%
Short Ratio (days to cover)0.60

Income Statement

In the last 12 months, AMAM had revenue of $7.46 million and -68.08 million in losses. Earnings per share was -$3.33.

Revenue7.46M
Gross Profit7.46M
Operating Income-64.42M
Pretax Income-68.08M
Net Income-68.08M
EBITDA-64.34M
EBIT-68.08M
Earnings Per Share (EPS)-$3.33
Full Income Statement

Balance Sheet

The company has $170.91 million in cash and $13.13 million in debt, giving a net cash position of $157.78 million or $4.09 per share.

Cash & Cash Equivalents170.91M
Total Debt13.13M
Net Cash157.78M
Net Cash Per Share$4.09
Book Value189.97M
Book Value Per Share4.92
Working Capital152.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$44.64 million and capital expenditures -$1.96 million, giving a free cash flow of -$46.60 million.

Operating Cash Flow-44.64M
Capital Expenditures-1.96M
Free Cash Flow-46.60M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -864.17% and -913.20%.

Gross Margin100.00%
Operating Margin-864.17%
Pretax Margin-913.19%
Profit Margin-913.20%
EBITDA Margin-863.07%
EBIT Margin-913.19%
FCF Margin-625.03%

Dividends & Yields

AMAM does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-45.82%
FCF Yield-31.36%
Dividend Growth (YoY)n/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Dividend Details

Analyst Forecast

The average price target for AMAM is $14.62, which is 279.74% higher than the current price. The consensus rating is "Buy".

Price Target$14.62
Price Target Difference279.74%
Analyst ConsensusBuy
Analyst Count10
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a